Yimutian Inc., a Chinese agricultural digital service company, has formally requested a hearing with Nasdaq's Hering Panel after receiving a delisting notice due to not meeting minimum market value requirements. The hearing request halts any immediate delisting, allowing Yimutian's shares to continue trading on Nasdaq. The company is actively working on strategic initiatives to regain compliance and increase its market value. However, there is no guarantee Yimutian will ultimately avoid delisting.
Liminatus Pharma received a delisting notice from Nasdaq due to failure to meet minimum market value requirements for its listed securities and publicly held shares. The company was given until May 18, 2026, to regain compliance but did not meet the ...
The SPDR S&P 500 High Dividend ETF (SPYD) has been given a reiterated 'Sell' rating because of its weak long-term total returns and low-quality holdings. Its simple yield-focused strategy lacks strong quality filters, leading to larger losses and poo...
President Trump signed an executive order on May 19, 2026, directing regulators to integrate digital assets like Bitcoin into traditional banking systems, encouraging banks to adopt blockchain technology faster. This move, alongside the Clarity Act w...
Bharti Airtel, India's second-largest telecom company, is increasing its stake in U.K.-listed Airtel Africa from 62.7% to 79% through a $2.9 billion cashless share-swap deal. It also aims to raise its shareholding in British telecom firm BT Group fro...
Tokens linked to real-world assets (RWA) and stable-value tokens reached new all-time highs recently, even as major cryptocurrencies like Bitcoin and Ethereum remain significantly below their previous peak prices. This divergence highlights a fragmen...
